Intuitive Surgical, Inc. reported a significant increase in financial performance for the first quarter of 2026, with total revenue reaching $2.77 billion, a 23% increase from $2.25 billion in the same period last year. The growth was driven by a 24% rise in systems revenue to $651 million and a 23% increase in instruments and accessories revenue, which totaled $1.69 billion. The company also saw a net income of $826 million, up from $704 million in the prior year, resulting in a diluted earnings per share of $2.28, compared to $1.92 in the first quarter of 2025.
In terms of operational metrics, approximately 847,000 da Vinci procedures were performed during the quarter, marking a 16% increase from 732,000 procedures in the same quarter of 2025. The company placed 431 da Vinci surgical systems, a 17% increase from 367 systems in the previous year. The installed base of da Vinci systems grew to approximately 11,395, reflecting a 12% increase year-over-year. Additionally, the Ion endoluminal system saw a 39% increase in procedures, with 42,700 performed in the first quarter of 2026.
Strategically, Intuitive Surgical completed the acquisition of the da Vinci and Ion distribution businesses from ab medica, Abex, and Excelencia Robótica for approximately $533 million. This acquisition allows the company to assume direct distribution responsibilities in Italy, Spain, Portugal, and Malta, enhancing its market presence in these regions. The company also repurchased 2.3 million shares of its common stock for $1.13 billion during the quarter, reflecting its commitment to returning value to shareholders.
The company’s cash and cash equivalents, along with short- and long-term investments, decreased to $7.98 billion as of March 31, 2026, down from $9.03 billion at the end of 2025. This decline was primarily due to cash used for stock repurchases and the recent acquisition. Intuitive Surgical anticipates continued growth in procedures and revenue, driven by the increasing adoption of robotic-assisted surgeries and the expansion of its product offerings. However, the company also noted potential challenges from macroeconomic factors, including inflation, interest rates, and geopolitical uncertainties, which could impact future performance.
About INTUITIVE SURGICAL INC
Intuitive Surgical designs and manufactures robotic-assisted surgical systems, primarily the da Vinci platform, and diagnostic endoluminal tools like Ion. Its products enhance minimally invasive procedures across multiple specialties, improving clinical outcomes, patient experience, and operational efficiency. The company serves hospitals and healthcare providers worldwide, offering integrated hardware, instruments, accessories, training, and support services to expand access to high-quality, less invasive care.
About 10-Q Filings
A 10-Q form is an important financial report that public companies in the United States must submit every three months. It gives a clear picture of a company's financial health and recent performance.
Key points about the 10-Q:
- Frequency: Companies file it three times a year, covering the first three quarters. The fourth quarter is covered in a more comprehensive annual report.
-
Content: It includes:
- Financial statements showing the company's current financial position
- Updates from management on the performance and projections of the business
- Information about potential risks the company faces
- Details on how the company is run internally
- Deadline: Must be filed within 40 or 45 days after the quarter ends, depending on the size of the company.
Our Methodology
AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.
Our method:
- Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
- AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
- Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
- Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
- Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Feedback & Corrections
Spot an error or have a suggestion? Contact us.